Background: Little is known about the direct effect of diabetes mellitus (DM) on medium-term to long-term lesion characteristics in patients treated with different types of stents.
Methods: A total of 261 stents enrolled in the multicenter study of intra-coronary angioscopy after stenting (MICASA) study were observed by coronary angioscopy about 1 year after percutaneous coronary intervention (PCI). There were 15 bare metal stents (BMS), 87 first-generation drug-eluting stents (1st-DES: 64 sirolimus-eluting stents [SES] and 23 paclitaxel-eluting stents [PES]), and 159 second-generation DES (2nd-DES: 73 everolimus-eluting stents [EES], 56 zotarolimus-eluting stents [ZES], and 30 biolimus-eluting stents [BES]). Neointimal coverage (NC) of the stents was classified into 4 grades from 0 (none) to 3 (complete). The maximum and minimum NC grades (Max-NC and Min-NC, respectively) were assessed for each stented segment, and the heterogeneity index was calculated by subtracting Min-NC from Max-NC. The color of plaques at stented segments was classified into four grades from 0 (white) to 3 (bright yellow). Thrombus was also investigated.
Results: In patients with DM, the yellow color grade was lower and the heterogeneity index was higher than in patients without DM for all stents (1.0 ± 0.8 vs. 1.2 ± 0.9, P = 0.050) and for BMS (2.0 ± 0.9 vs. 1.0 ± 0.9, P = 0.050), respectively. In addition, Min-NC was significantly higher and the plaque color grade was significantly lower in patients with DM than in those without DM for 1st-DES (Min-NC: 0.7 ± 0.6 vs. 0.4 ± 0.5, P = 0.009; color grade: 1.2 ± 0.9 vs. 1.7 ± 0.9, P = 0.006). Multivariate analysis revealed that DM was a significant negative predictor of yellow plaque (P = 0.048, OR: 0.600).
Conclusions: DM had the strongest influence on the chronic characteristics of coronary lesions, especially in patients treated with 1st-generation DES.
Progression of atheromatous plaque within neointima of coronary stents, which was termed neoatherosclerosis, has gained interest as a potential cause of very late stent failure. Pathologically, neoatherosclerosis was defined as the development of foamy macrophage clusters, fibroatheroma, thin-cap fibroatheroma, plaque rupture, and in-stent calcification within the stent. Following the pathological observations, a growing number of in vivo studies by using optical coherence tomography (OCT) and coronary angioscopy have been published to date. Those studies tried to clarify the features of neoatherosclerosis and have improved our knowledge substantially. Nevertheless, there still are missing information on natural history and clinical implications of neoatherosclerosis. The present review article summarized the definitions of neoatherosclerosis from the stands of view of pathology, OCT, and angioscopy. Moreover, what is known and what is not known regarding neoatherosclerosis were outlined for better understanding of pathophysiological consequences of coronary stents, which hopefully generates further ideas of clinical investigations.
Angioscopy is the only imaging modality that can directly evaluate the color of plaques. Therefore, nothing is more important to angioscopy than color. Plaque is classified into yellow plaque and white plaque according to their color. Yellow plaque has been considered to be vulnerable and high risk for the acute coronary syndromes, especially high-intense yellow plaque. Beta carotene is lipotorophic binding to lipid and coexisting with lipids in human atherosclerotic lesions and produces the yellow color of atherosclerotic plaque. Yellow plaque has several kinds of histopathology, such as a thin fibrous cap with lipid core, superficial or diffuse lipid deposition (cholesterol and cholesterol ester) with or without macrophage-foam cells and calcified plate. Therefore, all yellow plaques might not be vulnerable. Some pharmacological intervention and trans-catheter therapy decreased the intensity of yellow color. As angioscopic interpretation of color is usually subjective, objective computerized colorimetric evaluation is desirable.
The recent improvement of technical aspects of multimodality coronary imaging allow not only assessment of the degree of vessel luminal narrowing but also evaluation of the plaque characteristics and the useful prognostic information and accurate risk stratification. Among them, coronary angioscopy is the coronary imaging modality that enables direct visualization of internal surface of a vessel. Moreover it provides the detail information of plaque morphology, thrombus formation and neointimal coverage (NIC) after stent implantation. A lot of previous studies have shown that coronary angioscopy enabled not only the detection of vulnerable plaque but also prediction of cardiovascular events and percutaneous coronary intervention related complications. In this review, we discuss the role of coronary angioscopy for coronary plaque imaging, including in a comparison with other currently available imaging modalities used to examine atherosclerotic plaque.
August 28, 2017 There had been a service stop from Aug 28‚ 2017‚ 1:50 to Aug 28‚ 2017‚ 10:08(JST) (Aug 27‚ 2017‚ 16:50 to Aug 28‚ 2017‚ 1:08(UTC)) . The service has been back to normal.We apologize for any inconvenience this may cause you.
July 31, 2017 Due to the end of the Yahoo!JAPAN OpenID service, My J-STAGE will end the support of the following sign-in services with OpenID on August 26, 2017: -Sign-in with Yahoo!JAPAN ID -Sign-in with livedoor ID * After that, please sign-in with My J-STAGE ID.
July 03, 2017 There had been a service stop from Jul 2‚ 2017‚ 8:06 to Jul 2‚ 2017‚ 19:12(JST) (Jul 1‚ 2017‚ 23:06 to Jul 2‚ 2017‚ 10:12(UTC)) . The service has been back to normal.We apologize for any inconvenience this may cause you.
May 18, 2016 We have released “J-STAGE BETA site”.
May 01, 2015 Please note the "spoofing mail" that pretends to be J-STAGE.